TABLE 3.
Outcome and Predictors | b | OR (95% CI) |
Alcohol use previous 30 days, 6-month follow-up (n = 495) | ||
Motivational group | −0.40 | 0.67* (0.46, 0.97) |
Baseline alcohol use | 1.38 | 3.97*** (2.58, 6.11) |
HCV positive | −0.44 | 0.65* (0.44, 0.94) |
Alcohol use previous 30 days, 12-month follow-up (n = 447) | ||
Motivational condition | 0.01 | 1.01 (0.69, 1.49) |
Baseline alcohol use | 1.20 | 3.32*** (2.13, 5.20) |
HCV positive | −0.06 | 0.94 (0.64, 1.38) |
Used a new syringe last injection, 6-month follow-up (n = 503) | ||
Motivational group | 0.36 | 1.43 (0.79, 2.60) |
Used a new syringe last injection at baseline | 1.01 | 2.75** (1.37, 5.52) |
Used a new syringe last injection, 12-month follow-up (n = 454) | ||
Motivational group | 0.51 | 1.67 (0.97, 2.87) |
Used a new syringe last injection at baseline | 0.64 | 1.89 (0.97, 3.69) |
Unprotected vaginal or anal intercourse at last sexual encounter, 6-month follow-up (n = 436) | ||
Motivational group | 0.07 | 1.08 (0.69, 1.67) |
Unprotected intercourse at baseline | 1.81 | 6.09*** (3.76, 9.84) |
Primary partner | 1.30 | 3.68*** (2.29, 5.92) |
Unprotected vaginal or anal intercourse at last sexual encounter, 12-month follow-up (n = 397) | ||
Motivational group | 0.00 | 1.00 (0.65, 1.56) |
Unprotected intercourse at baseline | 1.40 | 4.04*** (2.55, 6.39) |
Primary partner | 0.90 | 2.46*** (1.54, 3.91) |
Note. OR = odds ratio; CI = confidence interval.
*P < .05; **P < .01; ***P < .001.